1Nseyo UO, Shumaker B, Klein EA, et al. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refraceory transitional cell carcino- ma in situ of the bladder[J]. J Urol,1998,160:39.
3Kriegmair M,Baumgartner R, Knuechel R, et al. Fluores- cencephotodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinie acid [J]. Urology, 1994,44:836.
4Kriegmair M, Baumgartner R, Knuechel R, et al. Detection of earlybladder cancer by 5-aminolevulinic acid induced porphyrinfluorescence[J]. Urol, 1996,155 : 105.
5Hungerhuber E, Stepp H, Kriegmair M, et al. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder[J]. Urology, 2007,69(2) :260.
6Inoue K, Karashima T, Kamada M, et al. Clinical experience with intravesical instillations of 5-aminolevulinic acid (5-ALA) for the photodynamic diagnosis using fluorescence cystoscopy for bladder cancer[J]. Nippon Hinyokika Gakkai Zasshi,2006,97(5) :719.
7Hallewin MA, Witte P, Waelkens E, et al. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillationof hypericin[J]. Urol, 2000,164 : 349.
8Hallewin MA, Kamuhabwa A, Roskanrs T, et al. Hypericin-based fluorescence diagnosis of bladder carcinoma[J]. BJU Int,2002,89:760.
9Pytel A,Schmeller N. New aspects of photodynamic diagnosis of bladder tumors:fluorescence cytology[J]. Urology,2002,59 :216.
10Casas A,Batlle A, Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy[J]. Curr Med Chem, 2006,13(10) : 1157.
4Schuitmaker JJ, Baas P, van-Leengoed HL, et al. Photodynamic therapy : a promising new modality for the treatment of cancer. J Photochem Photobiol B, 1996, 34: 3-12.
5Bachor R, Reich E, Miller K, et al. Photodynamic efficiency of liposome-administered tetrarnethyl hematoporphyrin in two humanbladder cancer cell lines. Urol Res, 1995, 23: 151-161.
6Bachor R, Reich E, Miller K, et al. Photodynamic efficiency of liposome-administered tetramethyl hematoporphyrin in two human bladder cancer cell lines. Urol Res, 1995, 23: 151-161.
7Uchibayashi T, Koshida K, Kunimi K, et al. Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder. Br J Cancer, 1995, 71: 625-628.
8Kriegmair M, Waidelich R, Lumper W, et al. Integral photody-namic treatment of refractory superficial bladder cancer. J Urol,1995, 154: 1339-1441.
9Jichlinski P, Wagnieres G, Forrer M, et al. Clinical assessment of fluorescence cytoscopy during transurethral bladder resection in superficial bladder cancer. Urol Res, 1997, 25( Suppl 1): S3-S6.
10Nseyo UO, Shumaker B, Klein EA, et al. Photodynamie therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of thebladder. Bladder Photoffin Study Group. J Urol, 1998, 160:39-44.
